Evidence map›Paper›PMID 35026374›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply.

Michele Bartoletti, Ozlem Azap, Aleksandra Barac, Linda Bussini, Onder Ergonul, Robert Krause, Alejandro Martín-Quirós, José Ramon Paño-Pardo, Nicholas Power, Marcella Sibani and 5 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Michele BartolettiInfectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. Electronic address: m.bartoletti@unibo.it.
Ozlem AzapDepartment of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Aleksandra BaracClinic for Infectious and Tropical Diseases, Univerzitetski Klinicki Centar Srbije, University Clinical Center of Serbia, Beograd, Serbia.
Linda BussiniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, Policlinico S Orsola-Malpighi, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Onder ErgonulSchool of Medicine, Infectious Diseases, Koc University, Istanbul, Turkey.
Robert KrauseSection of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Alejandro Martín-QuirósHospital Universitario La Paz, Unidad de Enfermedades Infecciosas, Madrid, Spain.
José Ramon Paño-PardoDivision of Infectious Diseases, Hospital Clínico Universitario "Lozano Blesa"-IIS Aragón, Zaragoza, Spain.
Nicholas PowerInfectious Diseases, University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK.
Marcella SibaniDepartment of Diagnostics and Public Health, Infectious Disease Section, University of Verona, Verona, Italy.
Balint SzaboSouth-Pest Central Hospital, National Institute of Haematology and Infectious Diseases, Saint Ladislaus Campus, Semmelweis University, School of PhD Studies, Budapest, Hungary.
Sotirios Tsiodras4th Department of Internal Medicine, National and Kapodistrian University of Athens-Faculty of Medicine, Athens, Greece.
Ines Zollner-SchwetzSection of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Jesús Rodriguez-BañoHospital Universitario Virgen Macarena, Enfermedades Infecciosas, Microbiologa y Medicina Preventiva, Universidad de Sevilla, Medicina, Sevilla, Spain.
ESCMID COVID-19 Treatment Guidelines Panel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentHumansSARS-CoV-2

Identifiers

PMID35026374
PMCPMC8744251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.